Roberto Valverde
3PUBLICATIONS
70CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Feb 01, 2024
Discovery of lirafugratinib (RLY-4008), a highly selective irreversible small-molecule inhibitor of FGFR2.Heike Schönherr, Pelin Ayaz, Alexander M Taylor
|Nov 02, 2023
Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Kα Inhibitor That Decouples Antitumor Activity from Hyperinsulinemia.Andreas Varkaris, Ermira Pazolli, Hakan Gunaydin
|Jun 04, 2023
RLY-4008, the First Highly Selective FGFR2 Inhibitor with Activity across FGFR2 Alterations and Resistance Mutations.Vivek Subbiah, Vaibhav Sahai, Dejan Maglic
Pageof 1
Frequent Collaborators
3 joint publications
David E Shaw
2 joint publications
Pelin Ayaz
2 joint publications
Hakan Gunaydin
2 joint publications
Beni B Wolf
2 joint publications
B Barry Touré
2 joint publications
Songping Zhao
2 joint publications
Alison M Schram
2 joint publications
Heike Schönherr
2 joint publications
Lindsey Foster
2 joint publications
Brandi M Hudson
